Gujarat Targets Biotechnology Leadership with Roadmap to Become Biomanufacturing Hub by 2030
Advertisement
Gujarat already contributes around 40% of India's pharmaceutical production and remains one of the country's largest chemical manufacturing centres.
Gujarat has unveiled an ambitious roadmap to establish itself as India's biotechnology and biomanufacturing hub by 2030, with a strong emphasis on developing skilled talent, expanding biotechnology education, and strengthening industry-ready training to support the country's fast-growing bio-economy.
The roadmap has been detailed in a report titled Gujarat Bio-Economy 2030: Strategic Skill Architecture and Workforce Development, released by the Gujarat Rajya Institute for Transformation (GRIT).
The country's bio-economy has expanded rapidly over the past decade, growing from nearly USD 10 Bn in 2014 to more than USD 150 Bn in 2024.
Supported by the Centre's BioE3 Policy (Biotechnology for Economy, Environment and Employment), India is now targeting a USD 300 Bn bio-economy by the end of this decade by promoting innovation, sustainable manufacturing, and advanced biotechnology research.
The report has highlighted Gujarat's existing industrial strengths and outlined how the state can build a future-ready biotechnology workforce while expanding its role in high-value biomanufacturing.
According to the report, Gujarat already contributes around 40% of India's pharmaceutical production and remains one of the country's largest chemical manufacturing centres.
"Under the leadership of Chief Minister Bhupendra Patel, the state aims to strengthen its position in biotechnology and biomanufacturing by leveraging its existing industrial base and expanding its skilled talent pool," an official said.
The report identified that biopharma currently accounts for nearly 35% of the bio-economy, supported by vaccines, therapeutics, and diagnostics.
A key recommendation of the report is the creation of a stronger biotechnology talent pipeline. The BioE3 Policy has identified skilled professionals and supporting infrastructure as essential for scaling high-performance biomanufacturing.
Strengthening education and specialised training could also reduce the migration of skilled professionals, minimise retraining requirements, and create a more sustainable workforce for the sector.
The report has also referred to the Gujarat State Biotechnology Policy 2022-27, which aims to move the state beyond large-scale production of generic medicines toward the development of innovative biologics.
Stay tuned for more such updates on Digital Health News
